Chronic anti-coagulation therapy reduced mortality in patients with high cardiovascular risk early in COVID-19 pandemic.
Journal Information
Full Title: Thromb J
Abbreviation: Thromb J
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Peripheral Vascular Disease
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."
"Funding This work was supported by grants from Veterans Affairs Clinical Research and Development (VA CSRD) COVID-19 rapid funding mechanism (COVID-19–8900-13; MAZ). This work was also supported by grants from NIH/NHLBI R01HL153436 (MAZ), R01HL150891 (MAZ), R01HL153262 (MAZ)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025